Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
General Motors Expands Cadillac EV Lineup with New Vistiq Targeting 300Mile Range Why US 10Year Bond Yields Serve as a Critical Market Barometer for Global Investors Minnesota Enacts Landmark Ban on Prediction Markets Making Operation a Felony Chinese Chip Stocks Rally in Hong Kong on Huawei Technology Optimism Kevin Warsh Sworn In as Federal Reserve Chair Amid Trumps Push for Lower Interest Rates Markets Anticipate Extended Pause HUBS Q1 2026 Earnings EPS Surges Past Estimates Revenue Growth Remains in Focus CNI Q1 2026 Earnings EPS Surpasses Estimates Modest Stock Uptick ITP Q3 2025 Earnings Net Loss Reported Amid Limited Financial Data MNSO Q4 2025 Earnings Massive EPS Beat of 88 Surprises Market Bassett Furniture Q1 2026 Earnings EPS Misses Estimates Amid Challenging Furniture Market Capital City Bank Group CCBG Holds Steady Amid Modest Decline Key Levels in Focus PIMCO Dynamic Income Strategy Fund PDX Edges Lower Amidst Narrow Trading Range Rave Restaurant Group RAVE Slips 24 as Price Tests Support Near 275 Oxbridge Re Holdings Warrant OXBRW Holds at 011 Amid Low Volatility Marvell Technology Shares Decline Despite Strong AIFueled Growth Outlook Puig Shares Fall Sharply Following Termination of Este Lauder Talks European Markets Edge Higher Samir Arora Challenges Jefferies View on SIPs and Rupee Weakness A Closer Look DoubleDigit Earnings Growth May Signal Bear Market Risk History Suggests SUPV Q1 2026 Earnings Massive EPS Beat Drives 732 Stock Surge Indian Rupee Opens Lower at 9626 Against US Dollar Amid Asian Currency Weakness and RBI Intervention Concerns ACU Q1 2026 Earnings Missed Earnings Estimates but Stock Gains on Operational Resilience HCA Q1 2026 Earnings EPS Falls Short of Expectations as Operating Pressures Linger JPMorgan Banker Lorna Hajdini Countersues Accuser Over Sexual Assault Allegations NTHI Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Development